Eli Lilly breaks ground on $6.5B Houston plant

Catch up quick: Lilly, one of the world's largest pharmaceutical companies, announced plans for the 236-acre Generation Park facility in September 2025. The plant will manufacture ingredients for drugs, including Foundayo, Lilly's oral GLP-1 weight-loss medication.

• The project is expected to create more than 600 permanent jobs and about 4,000 construction jobs.

What they're saying: "Texas is the global hub for life sciences," Gov. Greg Abbott said in a Lilly news release, calling the project "the largest active pharmaceutical ingredient project in Texas history."

• "This facility will run on the talent of this community," said Edgardo Hernandez, executive vice president and president of Lilly Manufacturing Operations, pointing to Lilly's partnership with San Jacinto College and plans to hire across the Houston area.

What's next: The facility is expected to be completed by 2030.